AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 4343464 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sedation with diazepam and atropine
Number of subjects: 65
Study 4343464 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sedation with chlormethiazole
Number of subjects: 65
Study 4343464 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-procedure risk
Number of subjects: 65
Study 31267576 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (Control): Answered a control question about prior night's sleep
Number of subjects: 2716
Study 31267576 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2: Answered sleep question and a question about fear of having blood drawn
Number of subjects: 2716
Study 31267576 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3: Answered sleep question, fear of having blood drawn question, and four questions about specific donation-related fears (seeing blood, needles, pain, fainting)
Number of subjects: 2716
Study 28627290 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous adductor canal block (ACB) with 0.2% ropivacaine, 20 mL bolus followed by continuous flow at 6 mL/h for 2 days
Number of subjects: 69
Study 28627290 — intervention group
Group type: COMPARATOR
Intervention: Single-dose local infiltration anesthesia (LIA) alone
Number of subjects: 69
Study 28627290 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous adductor canal block (ACB)
Number of subjects: 69
Study 25441094 — intervention group
Group type: EXPERIMENTAL
Intervention: Cpr + DF
Number of subjects: 79
Study 25441094 — intervention group
Group type: EXPERIMENTAL
Intervention: Tms + DF
Number of subjects: 79
Study 25441094 — intervention group
Group type: COMPARATOR
Intervention: AHT alone
Number of subjects: 79
Study 25441094 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 79
Study 24350813 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (maximum weight-based dose of 1.25 mg/day for 20 to <45 kg, and 1.75 mg/day for ≥ 45 kg)
Number of subjects: 79
Study 21679325 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpine skiing for 12 weeks (28.5 ± 2.6 skiing days)
Number of subjects: 22
Study 21679325 — intervention group
Group type: COMPARATOR
Intervention: Control group (no skiing training)
Number of subjects: 22
Study 18409002 — intervention group
Group type: EXPERIMENTAL
Intervention: pegylated interferon +/− lamivudine for 52 months
Number of subjects: 18
Study 15876429 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-symbolic arithmetic tasks
Number of subjects: 0
Study 13680248 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 205
Study 13680248 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 205
Study 10718508 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous intensity exercise training (HI, 80% Vo2max, n = 10)
Number of subjects: 18
Study 10718508 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise training (MOD, 40% Vo2max, n = 8)
Number of subjects: 18
Study 9535623 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate 0.5%
Number of subjects: 293
Study 9535623 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 293
Study 8357109 — intervention group
Group type: EXPERIMENTAL
Intervention: Home oximetry testing
Number of subjects: 240
Study 8357109 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative home oximetry test result
Number of subjects: 240
Study 8357109 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive home oximetry test result
Number of subjects: 240
Study 2875059 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) 200 micrograms b.i.d.
Number of subjects: 0
Study 2875059 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 0
Study 29544449 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic model including clinical and laboratory parameters
Number of subjects: 296
Study 29544449 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic model aiming for complete identification of sepsis cases
Number of subjects: 296
Study 29544449 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed model
Number of subjects: 296
Study 26676082 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmentation procedure
Number of subjects: 40
Study 26676082 — intervention group
Group type: COMPARATOR
Intervention: Nonaugmentation procedure
Number of subjects: 40
Study 24911814 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Group (topical capsaicin cream)
Number of subjects: 29
Study 24911814 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 29
Study 24911814 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Group
Number of subjects: 29
Study 23213981 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming-promoting needling technique
Number of subjects: 188
Study 23213981 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 188
Study 23213981 — intervention group
Group type: COMPARATOR
Intervention: Medication (salvia injectio and mecobalamin)
Number of subjects: 188
Study 20555377 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte solution (CES)
Number of subjects: 30
Study 20555377 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 30
Study 18569691 — intervention group
Group type: EXPERIMENTAL
Intervention: Recall of true negative events (M=3.31/5)
Number of subjects: 0
Study 18569691 — intervention group
Group type: EXPERIMENTAL
Intervention: Recall of true positive events (M=2.61/5)
Number of subjects: 0
Study 18569691 — intervention group
Group type: EXPERIMENTAL
Intervention: False events recalled (M=2.15 false events recalled)
Number of subjects: 0
Study 18569691 — intervention group
Group type: EXPERIMENTAL
Intervention: False negative events recalled
Number of subjects: 0
Study 18569691 — intervention group
Group type: EXPERIMENTAL
Intervention: False positive events recalled
Number of subjects: 0
Study 18569691 — intervention group
Group type: EXPERIMENTAL
Intervention: Detail of memories for negative events
Number of subjects: 0
Study 18569691 — intervention group
Group type: EXPERIMENTAL
Intervention: Detail of false negative event memories
Number of subjects: 0
Study 18569691 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissociation scores
Number of subjects: 0
Study 16415626 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant massage (tactile and kinesthetic stimulation), administered twice daily for 10 days.
Number of subjects: 26
Study 16415626 — intervention group
Group type: COMPARATOR
Intervention: Control group (no massage intervention).
Number of subjects: 26
Study 12444335 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% betamethasone‐17‐valerate ointment
Number of subjects: 8
Study 12444335 — intervention group
Group type: COMPARATOR
Intervention: Control petrolatum
Number of subjects: 8
Study 12444335 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus ointment
Number of subjects: 8
Study 10599897 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized multidisciplinary, outpatient 12‐month rehabilitation programme
Number of subjects: 50
Study 10599897 — intervention group
Group type: COMPARATOR
Intervention: Usual outpatient care
Number of subjects: 50
Study 8735556 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi capsular polysaccharide vaccine
Number of subjects: 0
Study 1930060 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 36
Study 1930060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 7022707 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesentericocaval shunt
Number of subjects: 49
Study 7022707 — intervention group
Group type: COMPARATOR
Intervention: Portacaval anastomosis
Number of subjects: 49
Study 30527907 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency (HF) rTMS at 10 Hz over the ipsilesional primary motor cortex (M1)
Number of subjects: 60
Study 30527907 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency (LF) rTMS at 1 Hz over the contralesional M1
Number of subjects: 60
Study 30527907 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 60
Study 28106767 — intervention group
Group type: EXPERIMENTAL
Intervention: e-CA (electronic mobile-based food record)
Number of subjects: 0
Study 28106767 — intervention group
Group type: EXPERIMENTAL
Intervention: e-CA
Number of subjects: 0
Study 28106767 — intervention group
Group type: COMPARATOR
Intervention: paper-based food record
Number of subjects: 0
Study 28106767 — intervention group
Group type: COMPARATOR
Intervention: 24-hour telephone recalls
Number of subjects: 0
Study 25920299 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Change plus Dental Care (LCDC) program
Number of subjects: 132
Study 25920299 — intervention group
Group type: COMPARATOR
Intervention: Routine program (Control)
Number of subjects: 132
Study 23327503 — intervention group
Group type: EXPERIMENTAL
Intervention: Twelve-Step Facilitation (TSF)
Number of subjects: 0
Study 23327503 — intervention group
Group type: COMPARATOR
Intervention: Integrated Cognitive-Behavioral Therapy (ICBT)
Number of subjects: 0
Study 21409705 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents' reports about their parents' parenting behaviors
Number of subjects: 252
Study 21409705 — intervention group
Group type: COMPARATOR
Intervention: Parent reports of parenting practices
Number of subjects: 252
Study 19788461 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular adsorbents recirculating system (MARS)
Number of subjects: 8
Study 19788461 — intervention group
Group type: EXPERIMENTAL
Intervention: Prometheus (FPAD)
Number of subjects: 8
Study 17429636 — intervention group
Group type: EXPERIMENTAL
Intervention: LEF (100 mg/day for 3 days followed by 20 mg/day)
Number of subjects: 40
Study 17429636 — intervention group
Group type: COMPARATOR
Intervention: MTX (25 mg once weekly)
Number of subjects: 40
Study 15617455 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg once daily
Number of subjects: 68
Study 15617455 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 20 mg once daily
Number of subjects: 68
Study 11348573 — intervention group
Group type: EXPERIMENTAL
Intervention: Coconut fat reduction (phase 1)
Number of subjects: 0
Study 11348573 — intervention group
Group type: EXPERIMENTAL
Intervention: Coconut fat reduction (phase 2, group A)
Number of subjects: 0
Study 11348573 — intervention group
Group type: EXPERIMENTAL
Intervention: Coconut fat reduction (phase 2, group B)
Number of subjects: 0
Study 9561096 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 300
Study 8489567 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate release formulation (300 mg, applied twice a day)
Number of subjects: 0
Study 8489567 — intervention group
Group type: COMPARATOR
Intervention: Sustained release formulation (400 mg, applied once a day in the evening)
Number of subjects: 0
Study 8489567 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate release formulation (300 mg)
Number of subjects: 0
Study 8489567 — intervention group
Group type: COMPARATOR
Intervention: Sustained release formulation (400 mg)
Number of subjects: 0
Study 3583456 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nourishment
Number of subjects: 14
Study 3583456 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nourishment
Number of subjects: 14
Study 3583456 — intervention group
Group type: COMPARATOR
Intervention: Oral and intravenous nourishment
Number of subjects: 14
Study 31088753 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching with 0s rest interval (R0)
Number of subjects: 15
Study 31088753 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching with 30s rest interval (R30)
Number of subjects: 15
Study 29957714 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (twice daily sessions of manual mobilization and 30‐minute passive/active cycling therapy)
Number of subjects: 21
Study 29957714 — intervention group
Group type: COMPARATOR
Intervention: Control group (manual mobilization once a day)
Number of subjects: 21
Study 29957714 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 21
Study 29957714 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study 27248838 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (aPDT)
Number of subjects: 46
Study 27248838 — intervention group
Group type: COMPARATOR
Intervention: Tongue scraper
Number of subjects: 46
Study 27248838 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue scraper and photodynamic therapy
Number of subjects: 46
Study 25171850 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated Exposure (RE) group; 0.2% salt w/w; n = 47
Number of subjects: 151
Study 25171850 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavor-Flavor Learning with Salt (FFL-Salt) group; 0.5% salt w/w; n = 54
Number of subjects: 151
Study 25171850 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavor-Flavor Learning with Nutmeg (FFL-Nutmeg) group; 0.2% salt and 0.02% nutmeg w/w; n = 50
Number of subjects: 151
Study 25171850 — intervention group
Group type: COMPARATOR
Intervention: Control vegetable (carrot puree)
Number of subjects: 151
Study 23002547 — intervention group
Group type: EXPERIMENTAL
Intervention: Kurarinol combined with Diammonium Glycyrrhizinate
Number of subjects: 63
Study 23002547 — intervention group
Group type: COMPARATOR
Intervention: Kurarinol (single drug group)
Number of subjects: 63
Study 19501011 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehension questionnaire administered at the end of the clinical trial
Number of subjects: 78
Study 18396361 — intervention group
Group type: EXPERIMENTAL
Intervention: Na-ASP-2 vaccine (10 microg)
Number of subjects: 36
Study 18396361 — intervention group
Group type: EXPERIMENTAL
Intervention: Na-ASP-2 vaccine (50 microg)
Number of subjects: 36
Study 18396361 — intervention group
Group type: EXPERIMENTAL
Intervention: Na-ASP-2 vaccine (100 microg)
Number of subjects: 36
Study 18396361 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 36
Study 15647416 — intervention group
Group type: EXPERIMENTAL
Intervention: Anidulafungin 200 mg intravenous loading dose followed by 100 mg intravenous maintenance dose (days 2-8)
Number of subjects: 12
Study 15647416 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine 1.25 mg/kg oral solution twice daily (days 5-8)
Number of subjects: 12
Study 12023065 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded hand grip strength test (GST) at four intensities
Number of subjects: 54
Study 12023065 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived exertion (RPE-C) recorded at the end of each load level
Number of subjects: 54
Study 12023065 — intervention group
Group type: EXPERIMENTAL
Intervention: Low grip force intensities
Number of subjects: 54
Study 10470636 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (10 mg of hyperbaric tetracaine intrathecally)
Number of subjects: 21
Study 10470636 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (fentanyl i.v. 1 to 2 micrograms/kg, propofol i.v. 1.0 to 2.0 mg/kg, isoflurane end-tidal 0.7% to 1.2%, 70% nitrous oxide in oxygen)
Number of subjects: 21
Study 9110278 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceleration plethysmography (APG)
Number of subjects: 390
Study 1765033 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (walking and jogging at a prescribed exercise intensity)
Number of subjects: 50
Study 1765033 — intervention group
Group type: COMPARATOR
Intervention: Non-aerobic strength and flexibility training
Number of subjects: 50
Study 1765033 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise and Non-aerobic strength and flexibility training
Number of subjects: 50
Study 1765033 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 50
Study 7085070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 20
Study 7085070 — intervention group
Group type: COMPARATOR
Intervention: Antacid
Number of subjects: 20
Study 31855259 — intervention group
Group type: EXPERIMENTAL
Intervention: Idelalisib (IDEL) for relapsed follicular lymphoma (FL)
Number of subjects: 26
Study 31855259 — intervention group
Group type: EXPERIMENTAL
Intervention: Idelalisib (IDEL) with rituximab (IDEL+R) for relapsed chronic lymphocytic leukemia (CLL)
Number of subjects: 26
Study 30716781 — intervention group
Group type: EXPERIMENTAL
Intervention: SED-ACT (interrupting sedentary time with high-intensity physical activity)
Number of subjects: 12
Study 30716781 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIE (high-intensity interval exercise session)
Number of subjects: 12
Study 30716781 — intervention group
Group type: COMPARATOR
Intervention: SED (prolonged uninterrupted sedentary time)
Number of subjects: 12
Study 28364511 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 74
Study 28364511 — intervention group
Group type: COMPARATOR
Intervention: Active Behavioral Desensitization Control (BD)
Number of subjects: 74
Study 28364511 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I) and Active Behavioral Desensitization Control (BD)
Number of subjects: 74
Study 26796052 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic treadmill training (NTT) for 30 minutes each day, 5 times per week for 6 weeks
Number of subjects: 30
Study 26796052 — intervention group
Group type: COMPARATOR
Intervention: Treadmill training (TT) for 30 minutes each day, 5 times per week for 6 weeks
Number of subjects: 30
Study 24508531 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural rehabilitation (PR) for 4 weeks
Number of subjects: 20
Study 24508531 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) applied to trunk muscles in 6 subjects
Number of subjects: 20
Study 24508531 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study 22075488 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based application with educational material and remote expert support (PCi)
Number of subjects: 4581
Study 22075488 — intervention group
Group type: COMPARATOR
Intervention: Control group with no access to web-based application (PCc)
Number of subjects: 4581
Study 19092728 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypoidal choroidal vasculopathy (PCV)
Number of subjects: 71
Study 19092728 — intervention group
Group type: EXPERIMENTAL
Intervention: Central serous chorioretinopathy
Number of subjects: 71
Study 19092728 — intervention group
Group type: EXPERIMENTAL
Intervention: Occult choroidal neovascularization secondary to age‐related macular degeneration
Number of subjects: 71
Study 19092728 — intervention group
Group type: EXPERIMENTAL
Intervention: Harada disease
Number of subjects: 71
Study 19092728 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinal macroaneurysms
Number of subjects: 71
Study 19092728 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis establishment
Number of subjects: 71
Study 19092728 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV in patients aged 60 and older
Number of subjects: 71
Study 17251875 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (50 mg/kg bolus followed by 8.3 mg/kg/hr infusion for 24 hr)
Number of subjects: 6
Study 17251875 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equivolume)
Number of subjects: 6
Study 15835374 — intervention group
Group type: EXPERIMENTAL
Intervention: Micardis (Telmisartan)
Number of subjects: 20
Study 15835374 — intervention group
Group type: EXPERIMENTAL
Intervention: Micardis (Telmisartan) with low-dose aspirin
Number of subjects: 20
Study 15835374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 12207634 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg methotrexate (MTX)
Number of subjects: 24
Study 12207634 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg methotrexate (MTX)
Number of subjects: 24
Study 12207634 — intervention group
Group type: EXPERIMENTAL
Intervention: AUC(24,36 h) >= 700 nmol l(‐1) h
Number of subjects: 24
Study 12207634 — intervention group
Group type: COMPARATOR
Intervention: AUC(24,36 h) < 700 nmol l(‐1) h
Number of subjects: 24
Study 10487104 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified hygiene with frequent handwashing and educational procedures
Number of subjects: 0
Study 10487104 — intervention group
Group type: COMPARATOR
Intervention: Observation group (control)
Number of subjects: 0
Study 8951627 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg 1 x daily for 3 days
Number of subjects: 46
Study 8951627 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 1758817 — intervention group
Group type: EXPERIMENTAL
Intervention: MS Contin tablet 200 mg (controlled release morphine sulphate)
Number of subjects: 0
Study 6138117 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphasalazine
Number of subjects: 90
Study 6138117 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium aurothiomalate
Number of subjects: 90
Study 6138117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 30343313 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% albumin
Number of subjects: 321
Study 30343313 — intervention group
Group type: COMPARATOR
Intervention: 4-5% albumin
Number of subjects: 321
Study 27199859 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal Assisted Therapy (AAT) treatment group (n = 14) participated in twice-weekly 1-hour sessions of AAT
Number of subjects: 22
Study 27199859 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 8) participated in one activity from a range of therapeutic activities that were part of the functional program
Number of subjects: 22
Study 25344101 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline decisional uncertainty
Number of subjects: 476
Study 25344101 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline informed subscale
Number of subjects: 476
Study 25344101 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant demographic and baseline measures
Number of subjects: 476
Study 25344101 — intervention group
Group type: EXPERIMENTAL
Intervention: State anxiety
Number of subjects: 476
Study 22206862 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-demographic factors (area-based deprivation scores)
Number of subjects: 1559